trial · primary record
Psilocybin
Treatment Resistant Depression
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 50 |
| Primary completion | 2031-02-01 |
| Primary endpoint | percentage number of participants with Adverse Events (AEs) |
| Registry ID | NCT07499583 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:36.972Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07499583
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.